Johnson & Johnson
Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets →
Analyst Sentiment
Johnson & Johnson is fairly valued at current levels. With our price target of $286.58 suggesting modest upside, the stock appears to be trading near fair value. Consider your portfolio allocation and investment timeline before making a decision.
The 24/7 Factor
5-Year Projection
Prediction History
| Date | Price Target | Stock Price | Rating | Upside |
|---|---|---|---|---|
| $296.25 | $268.04 | BUY | +10.5% | |
| $297.35 | $270.24 | BUY | +10.0% | |
| $288.79 | $260.35 | BUY | +10.9% | |
| $284.60 | $259.24 | BUY | +9.8% | |
| $283.70 | $256.35 | BUY | +10.7% | |
| $285.65 | $262.89 | BUY | +8.7% | |
| $282.60 | $249.97 | BUY | +13.1% |
Social Sentiment
Frequently Asked Questions
What is the JNJ stock price prediction for 2030?
Looking ahead to 2030, our model projects JNJ could trade at an average price of $329.32, with a potential range between $246.99 and $411.65. This represents a potential 19.6% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.
Is JNJ a buy, sell, or hold right now?
24/7 Wall St. currently rates JNJ as a HOLD. Near fair value (4.1%) Among Wall Street analysts, 16 rate it Buy, 6 rate it Hold, and 1 rate it Sell.
What is the JNJ stock price target in an optimistic scenario?
Our optimistic scenario for JNJ projects a price of $302.30 over the next 12 months. This represents modest upside of 9.8% from today’s price, suggesting the stock may be fairly valued at current levels even under favorable conditions.
What is the downside risk for JNJ stock?
In our conservative scenario, JNJ could trade as low as $246.37 over the next 12 months, representing a 10.5% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.
Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →